Single Dose Therapy of Zoledronic Acid for the Treatment of Transient Osteoporosis of Hip
Sanjay Agarwala, Mayank Vijayvargiya
Ann Rehabil Med. 2019;43(3):314-320.   Published online 2019 Jun 28     DOI: https://doi.org/10.5535/arm.2019.43.3.314
Citations to this article as recorded by Crossref logo
Comparison of various treatment modalities for the management of bone marrow edema syndrome/transient osteoporosis in men and non-pregnant women: a systematic review
Konstantinos Paraskevopoulos, Anthimos Keskinis, Ioannis S. Vasios, Konstantinos G. Makiev, Konstantinos Tilkeridis, Georgios I. Drosos, Athanasios N. Ververidis
Osteoporosis International.2023; 34(2): 269.     CrossRef
RANKL Blockade Reduces Cachexia and Bone Loss Induced by Non‐Metastatic Ovarian Cancer in Mice
Fabrizio Pin, Alexander J Jones, Joshua R Huot, Ashok Narasimhan, Teresa A Zimmers, Lynda F Bonewald, Andrea Bonetto
Journal of Bone and Mineral Research.2022; 37(3): 381.     CrossRef
Osteonecrosis in Patients Recovering from COVID-19: Mechanisms, Diagnosis, and Treatment at Early-Stage Disease (Review)
Alexander N. Torgashin, Svetlana S. Rodionova
Traumatology and Orthopedics of Russia.2022; 28(1): 128.     CrossRef
The Efficacy of Conservative Treatment of Bone Marrow Edema Syndrome: A Scoping Review of the Last Ten Years of Literature
Francesco Roberto Evola, Riccardo Compagnoni, Arianna Pieroni, Alberto Tassi, Alessandra Menon, Pietro Randelli
Journal of Clinical Densitometry.2022; 25(4): 506.     CrossRef
Prevalence of Transient Osteoporosis of the Hip Among Patients Presenting With Hip Pain in a Major Tertiary Hospital in Saudi Arabia
Asim S Aldhilan, Salma O Al-Amoudi, Sarah S Baabbad, Hamad M Al Jubair, Abdulmalik B Albaker, Yassir Edrees Almalki, Ali A Alamer, Sharifa Alduraibi, Ziyad A Almushayti, Suhayb Aldhilan
Cureus.2022;[Epub]     CrossRef
Bone marrow lesions: etiology and pathogenesis at the hip
Maria A Munsch, Marc R Safran, Matthew C Mai, W Kelton Vasileff
Journal of Hip Preservation Surgery.2021; 7(3): 401.     CrossRef
Treatment of aseptic necrosis of the femoral head. Clinical guidelines
A. N. Torgashin, S. S. Rodionova, A. A. Shumsky, M. A. Makarov, A. V. Torgashina, I. F. Akhtyamov, A. N. Kovalenko, N. V. Zagorodniy, S. P. Mironov
Rheumatology Science and Practice.2021; 58(6): 637.     CrossRef
Medikamentöse Therapie des primären Knochenmarködemsyndroms
Maximilian M. Delsmann, Constantin Schmidt, Julian Stürznickel, Florian Barvencik
Arthritis und Rheuma.2021; 41(04): 265.     CrossRef
Efficacy and Safety of Oral Ibandronate versus Intravenous Zoledronic Acid on Bone Metabolism and Bone Mineral Density in Postmenopausal Japanese Women with Osteoporosis
Masashi Uehara, Yukio Nakamura, Takako Suzuki, Masaki Nakano, Jun Takahashi
Journal of Clinical Medicine.2021; 10(22): 5420.     CrossRef
The efficacy and safety of bisphosphonates in patients with bone marrow edema syndrome/transient osteoporosis: A systematic literature review
Athanasios N. Ververidis, Konstantinos Paraskevopoulos, Anthimos Keskinis, Georgios I. Petkidis, Konstantinos Tilkeridis
Journal of Orthopaedics.2020; 22: 592.     CrossRef
Bisphosphonate Treatment Ameliorates Chemotherapy-Induced Bone and Muscle Abnormalities in Young Mice
Alyson L. Essex, Fabrizio Pin, Joshua R. Huot, Lynda F. Bonewald, Lilian I. Plotkin, Andrea Bonetto
Frontiers in Endocrinology.2019;[Epub]     CrossRef